13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix.
Lippman
S M
SM
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Kavanagh
J J
JJ
Paredes-Espinoza
M
M
Delgadillo-Madrueño
F
F
Paredes-Casillas
P
P
Hong
W K
WK
Massimini
G
G
Holdener
E E
EE
Krakoff
I H
IH
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D015474:Isotretinoin / Q000008:administration & dosage; D008875:Middle Aged; D011994:Recombinant Proteins; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D015474:Isotretinoin